Itoh T, Suzuki A, Watanabe Y, Mino T, Naka M, Tanaka T
Department of Pharmacology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
J Biol Chem. 1995 Sep 1;270(35):20400-3. doi: 10.1074/jbc.270.35.20400.
In permeabilized smooth muscle, exogenously applied calponin binds to myofibrils and reduces Ca(2+)-activated tension (Itoh, T., Suzuki, S., Suzuki, A., Nakamura, F., Naka, M., and Tanaka, T. (1994) Pflügers Arch. Eur. J. Physiol. 427, 301-308). A calponin peptide (calponin Phe173-Arg185), which inhibits the binding of calponin to actin, blocks the action of calponin and enhances the contraction induced by submaximal Ca2+ in permeabilized vascular smooth muscle. Unlike calmodulin, this peptide enhances the Ca(2+)-induced contraction without a corresponding increase in the level of myosin light chain phosphorylation. These results suggest that calponin decreases the sensitivity of smooth muscle to Ca2+ at a given level of myosin light chain phosphorylation.
在通透的平滑肌中,外源性施加的钙调蛋白结合到肌原纤维上,并降低Ca(2+)激活的张力(伊藤,T.,铃木,S.,铃木,A.,中村,F.,中,M.,和田中,T.(1994年)《普弗吕格尔斯文献。欧洲生理学杂志》427,301 - 308)。一种抑制钙调蛋白与肌动蛋白结合的钙调蛋白肽(钙调蛋白Phe173 - Arg185),可阻断钙调蛋白的作用,并增强通透的血管平滑肌中次最大Ca2+诱导的收缩。与钙调蛋白不同,该肽增强Ca(2+)诱导的收缩,而肌球蛋白轻链磷酸化水平没有相应增加。这些结果表明,在给定的肌球蛋白轻链磷酸化水平下,钙调蛋白降低了平滑肌对Ca2+的敏感性。